Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, August 05, 2020
The AAHRPP has awarded the Advarra institutional review board full reaccreditation.
read more
Wednesday, August 05, 2020
The FDA proposed to include four bulk drug substances on the list of bulk drug substances that outsourcing facilities may use in drug compounding consistent with section 503B of the Federal Food, Drug & Cosmetic Act.
read more
Wednesday, August 05, 2020
Quest announced the FDA has granted EUA for a new laboratory technique that speeds the process of extracting viral RNA from specimens to expand its daily capacity of COVID-19 molecular diagnostic tests on behalf of patients.
read more
Wednesday, August 05, 2020
The Ethypharm Group announced its facility located in Romford has successfully passed its first FDA inspection.
read more
RedHill Biopharma has replaced its existing co-commercialization agreement with Daiichi Sankyo, for Movantik, which was assigned to RedHill under its April 2020 acquisition agreement with AstraZeneca.
read more
The FDA has announced the retirement of the MedWatch to Manufacturer Program.
read more
The 6000TOCi on-line TOC sensor delivers reliable data to demonstrate compliance in Pharmaceutical water systems.
read more
PAO Group has previewed its next acquisition after closing the acquisition of a cannabis biopharmaceutical asset to treat COPD and a cannabis cultivation operation developing a proprietary cannabis cultivar.
read more
Abzena has announced the appointment of Matthew LeClair as Senior Vice President (SVP) and Site Head of its San Diego Operations.
read more
Otonomy announced a license agreement with KYORIN that provides exclusive worldwide rights to develop, manufacture and commercialize a novel compound for sensorineural hearing loss.
read more
CRL has received EUA and is scaling up capacity for CRL Rapid Response, a saliva-based COVID-19 RT-PCR test that can be self-collected.
read more
Clinical Ink announced its acquisition by GI Partners, a private equity investment firm.
read more
Horizon Discovery Group has announced the addition of single cell RNAseq-linked pooled CRISPR screening to its CRISPR screening services portfolio.
read more
Catalent will expand its Argentinian site in Loma Hermosa, Buenos Aires.
read more
PharmaLex Group has added Sébastien Schmitt to the company’s senior management team.
read more